Masimo EBITDA 2007-2019 | MASI

Masimo annual and quarterly EBITDA history from 2007 to 2019. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Masimo EBITDA for the quarter ending December 31, 2019 was $0.067B, a 14.22% increase year-over-year.
  • Masimo EBITDA for the twelve months ending December 31, 2019 was $0.245B, a 6.78% increase year-over-year.
  • Masimo 2019 annual EBITDA was $0.245B, a 6.78% increase from 2018.
  • Masimo 2018 annual EBITDA was $0.229B, a 12.42% increase from 2017.
  • Masimo 2017 annual EBITDA was $0.204B, a 54.98% decline from 2016.
Masimo Annual EBITDA
(Millions of US $)
2019 $245
2018 $229
2017 $204
2016 $453
2015 $136
2014 $116
2013 $91
2012 $95
2011 $94
2010 $113
2009 $88
2008 $77
2007 $72
2006 $313
2005 $12
Masimo Quarterly EBITDA
(Millions of US $)
2019-12-31 $67
2019-09-30 $58
2019-06-30 $58
2019-03-31 $61
2018-12-31 $59
2018-09-30 $54
2018-06-30 $57
2018-03-31 $59
2017-12-31 $50
2017-09-30 $48
2017-06-30 $49
2017-03-31 $57
2016-12-31 $330
2016-09-30 $41
2016-06-30 $41
2016-03-31 $41
2015-12-31 $41
2015-09-30 $32
2015-06-30 $32
2015-03-31 $31
2014-12-31 $36
2014-09-30 $26
2014-06-30 $21
2014-03-31 $33
2013-12-31 $16
2013-09-30 $24
2013-06-30 $26
2013-03-31 $26
2012-12-31 $25
2012-09-30 $20
2012-06-30 $25
2012-03-31 $24
2011-12-31 $22
2011-09-30 $21
2011-06-30 $24
2011-03-31 $27
2010-12-31 $23
2010-09-30 $24
2010-06-30 $23
2010-03-31 $42
2009-12-31 $23
2009-09-30 $22
2009-06-30 $22
2009-03-31 $22
2008-12-31 $22
2008-09-30 $22
2008-06-30 $18
2008-03-31 $15
2007-12-31 $18
2007-09-30 $18
2007-06-30 $20
2007-03-31 $17
2006-09-30 $21
2006-06-30 $22
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.274B $0.938B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $112.928B 22.95
Intuitive Surgical (ISRG) United States $58.547B 43.42
Edwards Lifesciences (EW) United States $41.707B 35.81
ALCON INC (ALC) Switzerland $23.570B 0.00
DexCom (DXCM) United States $22.918B 136.73
IDEXX Laboratories (IDXX) United States $19.658B 47.21
Fresenius Medical Care AG KGaA (FMS) Germany $19.129B 12.67
Olympus (OCPNY) Japan $18.833B 141.44
Sysmex ADR (SSMXY) Japan $14.401B 40.59
Teleflex (TFX) United States $13.445B 26.01
SONOVA HOLDING (SONVY) Switzerland $11.508B 0.00
STERIS (STE) Ireland $10.993B 23.44
Varian Medical Systems (VAR) United States $9.812B 22.83
Hologic (HOLX) United States $8.958B 13.77
SARTORIUS AG (SARTF) Germany $7.766B 69.00
ABIOMED (ABMD) United States $6.722B 35.43
Penumbra (PEN) United States $5.576B 164.00
Globus Medical (GMED) United States $4.303B 25.50
Tandem Diabetes Care (TNDM) United States $3.892B 0.00
Wright Medical Group (WMGI) Netherlands $3.697B 410.29
Integra LifeSciences Holdings (IART) United States $3.443B 14.88
Nevro (NVRO) United States $3.033B 0.00
Elekta AB (EKTAY) Sweden $2.995B 23.06
Nihon Kohden (NHNKY) Japan $2.830B 28.48
LivaNova (LIVN) United Kingdom $2.065B 15.06
Integer Holdings (ITGR) United States $1.985B 12.93
Glaukos (GKOS) United States $1.627B 0.00
Cantel Medical (CMD) United States $1.502B 14.45
Veracyte (VCYT) United States $1.224B 0.00
Luminex (LMNX) United States $1.223B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.222B 23.91
Inogen (INGN) United States $1.209B 51.30
ShockWave Medical (SWAV) United States $1.098B 0.00
Silk Road Medical (SILK) United States $1.044B 0.00
Mesa Laboratories (MLAB) United States $0.962B 50.38
OPKO Health (OPK) United States $0.924B 0.00
Natus Medical (NTUS) United States $0.787B 18.46
Tactile Systems Technology (TCMD) United States $0.772B 71.73
CryoLife (CRY) United States $0.635B 52.45
OrthoPediatrics (KIDS) United States $0.612B 0.00
Pacific Biosciences Of California (PACB) United States $0.547B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.530B 18.78
Accelerate Diagnostics (AXDX) United States $0.445B 0.00
Intersect ENT (XENT) United States $0.410B 0.00
AngioDynamics (ANGO) United States $0.403B 18.48
AxoGen (AXGN) United States $0.386B 0.00
ViewRay (VRAY) United States $0.372B 0.00
Si-Bone (SIBN) United States $0.312B 0.00
Quotient (QTNT) Switzerland $0.301B 0.00
TransMedics (TMDX) United States $0.273B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.259B 0.00
GenMark Diagnostics (GNMK) United States $0.250B 0.00
Alphatec Holdings (ATEC) United States $0.233B 0.00
IRadimed (IRMD) United States $0.233B 26.41
Semler Scientific (SMLR) United States $0.229B 27.42
SeaSpine Holdings (SPNE) United States $0.217B 0.00
Stereotaxis (STXS) United States $0.184B 0.00
Fluidigm (FLDM) United States $0.169B 0.00
Accuray (ARAY) United States $0.159B 0.00
RTI Surgical (RTIX) United States $0.155B 42.00
Restoration Robotics (VERO) Canada $0.117B 0.00
Sientra (SIEN) United States $0.115B 0.00
Electromed (ELMD) United States $0.103B 28.14
CRH Medical (CRHM) Canada $0.094B 26.20
Spectral Diagnostics (EDTXF) Canada $0.085B 0.00
Vermillion (VRML) United States $0.072B 0.00
Allied Healthcare Products (AHPI) United States $0.067B 0.00
EDAP TMS S.A (EDAP) France $0.066B 17.61
MRI Interventions (CLPT) United States $0.059B 0.00
ConforMIS (CFMS) United States $0.050B 0.00
Sensus Healthcare (SRTS) United States $0.046B 0.00
Apollo Endosurgery (APEN) United States $0.045B 0.00
Second Sight Medical Products (EYES) United States $0.043B 0.00
T2 Biosystems (TTOO) United States $0.031B 0.00
Neuronetics (STIM) United States $0.031B 0.00
Bioanalytical Systems (BASI) United States $0.027B 0.00
DarioHealth (DRIO) Israel $0.022B 0.00
Neovasc (NVCN) Canada $0.020B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.019B 0.00
TransEnterix (TRXC) United States $0.018B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.016B 0.00
Ra Medical Systems (RMED) United States $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Nanovibronix (NAOV) United States $0.011B 0.00
Dynatronics (DYNT) United States $0.011B 0.00
Sunshine Heart Inc (CHFS) United States $0.009B 0.00
American Shared Hospital Services (AMS) United States $0.009B 12.92
Helius Medical Technologies (HSDT) United States $0.009B 0.00
Xtant Medical Holdings (XTNT) United States $0.008B 0.00
Avinger (AVGR) United States $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.007B 0.00
Lianluo Smart (LLIT) China $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
ReWalk Robotics (RWLK) Israel $0.006B 0.00
OBALON THERPTCS (OBLN) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.003B 0.00
Viveve Medical (VIVE) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00